Sequent Scientific Ltd.
| BSE: 512529 | Sector: Health care |
| NSE: SEQUENT | ISIN Code: INE807F01027 |
| BSE 16:00 | 15 Jun | 276.05 |
9.25 (3.47%) |
OPEN
267.00 |
HIGH
279.50 |
LOW
267.00 |
| NSE 15:59 | 15 Jun | 276.25 |
9.65 (3.62%) |
OPEN
267.60 |
HIGH
280.00 |
LOW
266.85 |
| OPEN | 267.00 |
| PREVIOUS CLOSE | 266.80 |
| VOLUME | 149378 |
| 52-Week high | 311.95 |
| 52-Week low | 84.50 |
| P/E | 184.03 |
| Mkt Cap.(Rs cr) | 6,856 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Sequent Scientific Ltd. (SEQUENT) - Company Information
Sequent Scientific Ltd
Visistha Traders & Finance Ltd has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12 2003....> More
| COMPANY INFORMATION | |||||||
| Chairman & Independent Directo : | Gopakumar G Nair | ||||||
| Independent Director : | Kausalya Santhanam | ||||||
| Managing Director & CEO : | Manish Gupta | ||||||
| Joint Managing Director : | Sharat Narasapur | ||||||
| Company Secretary : | Krunal Shah | ||||||
| Addtnl Non-Executive Director : | Neeraj Bharadwaj | ||||||
| Addtnl Non-Executive Director : | Rahul Mukim | ||||||
| Additional Director : | Gregory John Andrews | ||||||
| Additional Director : | Fabian Kausche | ||||||
| AUDITOR : | S R B C & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | MNC Associate | ||||||
| Registered office | |||||||
| 301 Dosti Pinnacle 3rd Floor, Plot E7 Road No 22 Wagle Indl,Thane,Maharashtra-400604 | |||||||
| Ph : 91-022-41114777 | |||||||
| WEBSITE : http://www.pidrugs.com | |||||||
| E-mail : pidsecretarial@yahoo.co.in | |||||||
Quick Links for Sequent Scientific:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
